Gene originating in human chondrocyte

a human chondrocyte and gene technology, applied in the field of human chondrocyte gene origin, can solve the problems of difficult to search for human chondrocyte specific gene expression, cell culture system useful in analysis, and method for monolayer culturing human chondrocytes in a differentiated state has not yet been established, so as to facilitate analysis of chondrocyte properties in a differentiated sta

Inactive Publication Date: 2005-08-25
CHUGAI PHARMA CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This approach enables the successful monolayer culture of human chondrocytes in a differentiated state, facilitating the identification of genes uniquely expressed in this condition and providing tools for analyzing cartilage differentiation and degeneration, as well as developing gene therapies for osteoarthritis and rheumatoid arthritis.

Problems solved by technology

However, any method for monolayer culturing human chondrocytes in a differentiated state has not yet been established, although culture systems for rabbit or chicken chondrocytes in a differentiated state have been developed.
Accordingly, it is difficult to search for genes that are expressed specifically in human chondrocytes in a differentiated state thereof; there has not been provided any cell culture system useful in analyzing the properties of the chondrocytes in a differentiated state thereof.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene originating in human chondrocyte
  • Gene originating in human chondrocyte
  • Gene originating in human chondrocyte

Examples

Experimental program
Comparison scheme
Effect test

example 1

Culture of Chondrocytes in Differentiated State

[0071] Epiphyseal cartilage of the femur knee joint of a human fetus that was naturally aborted about 25 weeks of pregnancy (obtained from Norman Bethune University of Medical Sciences, Department of Pathology) was obtained. Chondrocytes were isolated from this cartilage according to the same method as that described in Shimomura et al. Calcif. Tissue Res. 19, 179-187 (1975), except that the finely cut cartilage was incubated in a α-modified Eagle's medium (α-MEM) containing 3 mg / ml collagenase (Type IA, Sigma) for 3 h. The cells were seeded at 1×105 cells per Type I collagen-coated dish and maintained in α-MEM (10 ml / dish) containing 10% fetal bovine serum, 50 μg / ml of ascorbic acid, 32 unit / ml of penicillin, and 40 μg / ml of streptomycin. Dibutyryl cAMP (dbcAMP) (1 mM) was added to the culture medium when the cells became subconfluent. Cells were cultured over two days either in the presence or in the absence of dbcAMP. Then, while th...

example 3

(1) Materials and Methods

[0082] Chondrocytes were isolated from the rib growth plate and resting cartilage of ribs of a male Japanese white rabbit (four-weeks old) according to the method as already reported in Shimomuraet al. Calcif. Tissue Res. 19, 179-187 (1975).

[0083] These cells were seeded at 5×105 cells per 10 mm plastic culture dish and maintained in 10 ml of α-MEN supplemented with 10% FBS, 60 mg / ml of kanamycins, 250 ng / ml of amphotericin B, and 50 unit / ml of penicillin G at 37° C. in the air containing 5% CO2. After cells reached confluent, the cells were washed with PBS, transferred to a fresh α-MEN (10 ml) containing no serum, and maintained for 48 h. From 1 to 24 h before the completion of incubation, 1 mM dbcAMP or 10×x−7 M human recombinant PTH-(1-84) was added to the medium.

[0084] Human embryonic pulmonary fibroblasts (MRC-5), human cervix uteri epithelial cells (Hela), human hepatoma cells (HepG2) and canine renal epithelial cells (MDCK) were obtained from the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention provides a gene specifically expressed in differentiated human chrondrocytes. By culturing the chrondrocytes in the presence of dibutyryl cAMP, the chrondrocytes are cultured in a differentiated state and any gene is searched for which has a distinction in expression between differentiated chrondrocytes and dedifferentiated chrondrocytes. This allows the gene specifically expressed in the former to be obtained.

Description

TECHNICAL FIELD [0001] This invention relates to a gene expressed specifically in differentiated chondrocytes originating in human (or human chondrocytes), a protein encoded by the gene, an antibody capable of binding to the protein, a method for culturing human chondrocytes in a differentiated state, and human chondrocytes that have been cultured by the method. BACKGROUND ART [0002] Searching for genes expressed specifically in chondrocytes in a differentiated state and analysis of the properties of the chondrocytes are not only important in analyzing the mechanism of differentiation and degeneration of cartilage, but also are indispensable for developing gene therapy for osteoarthritis and rheumatoid arthritis. [0003] However, any method for monolayer culturing human chondrocytes in a differentiated state has not yet been established, although culture systems for rabbit or chicken chondrocytes in a differentiated state have been developed. (Kato et al. Proc. Natl. Acad. Sci. USA 8...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C07K14/47C12N5/077C12N15/12
CPCC07K14/47C12N2501/01C12N5/0655C07K14/4702
InventorKATOKAWAMOTO, TAKESHI
OwnerCHUGAI PHARMA CO LTD